These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10570948)

  • 1. Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.
    Ruiz L; Miguel A; Díaz-Laviada I
    FEBS Lett; 1999 Sep; 458(3):400-4. PubMed ID: 10570948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.
    Sánchez C; Galve-Roperh I; Canova C; Brachet P; Guzmán M
    FEBS Lett; 1998 Sep; 436(1):6-10. PubMed ID: 9771884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1.
    Velasco L; Ruiz L; Sánchez MG; Díaz-Laviada I
    Eur J Biochem; 2001 Feb; 268(3):531-5. PubMed ID: 11168391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids enhance human B-cell growth at low nanomolar concentrations.
    Derocq JM; Ségui M; Marchand J; Le Fur G; Casellas P
    FEBS Lett; 1995 Aug; 369(2-3):177-82. PubMed ID: 7544292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
    Araya KA; David Pessoa Mahana C; González LG
    Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internalization and recycling of the CB1 cannabinoid receptor.
    Hsieh C; Brown S; Derleth C; Mackie K
    J Neurochem; 1999 Aug; 73(2):493-501. PubMed ID: 10428044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
    Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
    Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.
    Sánchez C; Velasco G; Guzmán M
    Life Sci; 1997; 60(19):1709-17. PubMed ID: 9129126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
    Tanda G; Pontieri FE; Di Chiara G
    Science; 1997 Jun; 276(5321):2048-50. PubMed ID: 9197269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism.
    Ramer R; Brune K; Pahl A; Hinz B
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1144-52. PubMed ID: 11527419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ; Hampson RE; Deadwyler SA; Childers SR
    J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
    Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
    Lauckner JE; Hille B; Mackie K
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme.
    Blázquez C; Sánchez C; Daza A; Galve-Roperh I; Guzmán M
    J Neurochem; 1999 Apr; 72(4):1759-68. PubMed ID: 10098887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
    J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
    Shivachar AC; Martin BR; Ellis EF
    Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.